Skip to main content

Table 3 Characteristics of included studies

From: The effectiveness of extracorporeal shock wave therapy for the treatment of lower limb ulceration: a systematic review

Primary author

Outcomes measured

Study design

Number allocated to (a) experimental and (b) control groups

Mean age years (SD)

% female

Mean duration of disease in months (SD)

Ulcer classification

ESWT protocol

Moretti [26]

Rate of re-epithelialization

RCT

(a) 15

56.2 ± 4.9

40

UD

Neuropathic (diabetic) plantar foot ulceration ≥6 months duration; area >1 cm2 and diameter between 0.5 and 5 cm

3 sessions (every 72 hours); 100 pulses per 1 cm2; EFD 0.03 mJ/mm2

15

56.8 ± 7.5

53

UD

Saggini [27]

Exudate,

Quasi-experimental

(a) 30

58.5

43

5.3

Venous ulcers; diabetic ulcers; unresponsive to conservative care for ≥3 months duration

4 to 10 sessions; 100 impulses per 1 cm2; EFD 0.037 mJ/mm2; frequency of 4 Hz or 240 impulses/min

Granulation and

10

66.6

40

5.2

Fibrin/necrotic tissue

Wang [28]

Healing rates

RCT

(a) 34

58.6 ± 12.6

UD

22.7 ± 20.9

Diabetic foot ulcer >3 months duration

3 treatments; repeat course performed in cases with incomplete healing; 300 plus 100 pulses per 1 cm2; EFD 0.11 mJ/cm2

Histopathological analysis

(a) 36

63.4 ± 10.3

UD

19.0 ± 19.5

Wang [29]

Healing rates

RCT

(a) 39

60.5 ± 14.0

UD

6* (3 to16)

Diabetic foot ulcer >3 months duration

6 treatments; Ulcer size dependent treatment; minimum 500 pulses; EFD 0.27 mJ/cm2

Histopathological analysis

(a) 38

62.5 ± 14.0

UD

6* (6 to10)

Schaden [17]

Safety and feasibility of ESWT

Case-series

(a) 31

61.0

48

UD

Complicated, non-healing, acute and chronic venous and arterial ulcers

Mean sessions 1.9 to 3.7; 100 impulses per 1 cm2; EFD 0.1 mJ/mm2

  1. Notes:
  2. EFD: energy flux density; RCT: randomised controlled trial.
  3. SD: standard deviation; UD: unable to determine.
  4. *Median value (range) reported.
  5. ESWT = extracorporeal shock wave therapy.